Asia - International Biopharmaceutical Industry

Current Edition

news

WHO SE Asia Region Parliamentarians make stronger commitments

The momentum picked up in recent years with WHO declaring ‘reducing preventable maternal, child and neonatal deaths’ as a flagship programme in South-East Asia Region...

31 July 2018 news Asia | commitments

Continue Reading →

news

AHH raises $50 million from Sheares Healthcare

AHH to leverage expertise of leading healthcare executives and investors to transform specialty healthcare in South Asia Asia Healthcare Holdings (AHH), an operating...

6 July 2018 news $50M | AHH

Continue Reading →

news

Agendia, Angsana partner for cancer treatment in Southeast Asia

Partnership will enable women in Singapore, Malaysia, Vietnam, Brunei and Myanmar to access the benefits of MammaPrint® and BluePrint® to personalize treatment mana...

25 May 2018 news Agendia | Angsana

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

WHO SE Asia Region Parliamentarians make stronger commitments

AHH raises $50 million from Sheares Healthcare

Agendia, Angsana partner for cancer treatment in Southeast Asia

International Biopharmaceutical Industry